Are you Dr. Zhao?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8118 Good Luck Rd
Lanham, MD 20706Phone+1 301-552-8149
Summary
- Dr. Bin Zhao, MD is a board certified pathologist in Lanham, Maryland. He is currently licensed to practice medicine in Maryland, Virginia, and District of Columbia. He is affiliated with Luminis Health Doctors Community Medical Center and Holy Cross Hospital.
Education & Training
- George Washington UniversityResidency, Pathology-Anatomic and Clinical, 2012 - 2016
- Conemaugh Memorial Medical CenterResidency, Pathology-Anatomic and Clinical, 2012 - 2016
- Shanxi Medical UniversityClass of 1985
Certifications & Licensure
- VA State Medical License 2017 - 2026
- MD State Medical License 2019 - 2025
- PA State Medical License 2012 - 2024
- DC State Medical License 2012 - 2016
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Clinical Trials
- Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- Response to: Energy sensor AMPKγ does not exist in isolation from AMPKα or interact with PPP6C in muscle and liver from humans and mice.Qi Zhou, Xiaolei Cao, Bin Zhao
Molecular Cell. 2024-05-02 - Exosome at the crossroads of mechanosensing and liver tumorigenesis.Mei Tang, Chenliang Wang, Bin Zhao
Science Bulletin. 2023-12-30 - 1 citationsGRK5 Deficiency in the Hippocampus Leads to Cognitive Impairment via Abnormal Microglial Alterations.Hongtao Shen, Tianzhen Zhang, Yao Ji, Yu Zhang, Yongxiang Wang
Molecular Neurobiology. 2023-03-01
Press Mentions
- Identification of Key Genes and Pathways in Scleral Extracellular Matrix Remodeling in Glaucoma: Potential Therapeutic Agents Discovered Using Bioinformatics AnalysisFebruary 4th, 2021
- Identification of Key Genes and Pathways in Scleral Extracellular Matrix Remodeling in Glaucoma: Potential Therapeutic Agents Discovered Using Bioinformatics AnalysisFebruary 4th, 2021
- Holonyak Lab Team Creates Fast, Cheap, Accessible COVID-19 Antibody TestFebruary 1st, 2021
- Join now to see all